Abiopharma

ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Palladyne AI’s GuideTech Wins New $2.3 Million Contract for BRAIN with Defense Prime Continuing Commercial Momentum

Kirby Corporation Announces Date for 2026 Second Quarter Earnings Release and Earnings Webcast

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company